Longevity Health Holdings Inc banner

Longevity Health Holdings Inc
NASDAQ:XAGE

Watchlist Manager
Longevity Health Holdings Inc Logo
Longevity Health Holdings Inc
NASDAQ:XAGE
Watchlist
Price: 0.311 USD Market Closed
Market Cap: $771.3k

Longevity Health Holdings Inc
Current Portion of Long-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Longevity Health Holdings Inc
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Longevity Health Holdings Inc
NASDAQ:XAGE
Current Portion of Long-Term Debt
$241.2k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Current Portion of Long-Term Debt
$6.1B
CAGR 3-Years
14%
CAGR 5-Years
-6%
CAGR 10-Years
12%
Gilead Sciences Inc
NASDAQ:GILD
Current Portion of Long-Term Debt
$2.8B
CAGR 3-Years
7%
CAGR 5-Years
0%
CAGR 10-Years
11%
Amgen Inc
NASDAQ:AMGN
Current Portion of Long-Term Debt
$4.6B
CAGR 3-Years
42%
CAGR 5-Years
119%
CAGR 10-Years
7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Longevity Health Holdings Inc
Glance View

Market Cap
771.3k USD
Industry
Biotechnology

Longevity Health Holdings, Inc. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 9 full-time employees. The company went IPO on 2021-07-29. The firm utilizes the Carmell Secretome to support skin and hair health. The Carmell Secretome consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from United States Food and Drug Administration-approved tissue banks. The firm has developed a micellar nanoparticle formulation that enables the delivery of lipophilic and hydrophilic ingredients without relying on the harmful excipients that are used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. Additionally, its micellar formulations do not utilize mineral or vegetable oils across their entire product line and are designed to be non-comedogenic. The firm is also developing a line of men’s products and a line of topical haircare products.

XAGE Intrinsic Value
Not Available

See Also

What is Longevity Health Holdings Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
241.2k USD

Based on the financial report for Dec 31, 2024, Longevity Health Holdings Inc's Current Portion of Long-Term Debt amounts to 241.2k USD.

What is Longevity Health Holdings Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 1Y
-81%

Over the last year, the Current Portion of Long-Term Debt growth was -81%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett